TABLE 1.
Demographic and baseline clinical and virological characteristics of subjects with primary HIV-1 infection
Subject no. | Age (yr) | Ethnicity | Seroconversiona
|
Baseline values
|
||||
---|---|---|---|---|---|---|---|---|
Last negative EIA (dpi) | First positive EIA (dpi) | dpi | Plasma viral load (RNA counts/ml) | CD4 count (cells/μl) | CD8 count (cells/μl) | |||
1168 | 20 | Caucasian | −26 | 18 | 9 | 556,728 | 548 | 429 |
1184 | 28 | Hispanic | None | 7 | 26 | 4,110 | 601 | 789 |
1188 | 23 | Hispanic | −28 | 62 | 79 | 73,074 | 409 | 1,172 |
1201 | 27 | Caucasian | −129 | 24 | 4 | >750,000 | 775 | 1,072 |
1212 | 37 | Caucasian | 11 | 17 | 5 | >750,000 | 755 | 481 |
1224 | 41 | Caucasian | −28 | 7 | 7 | 43,500 | 537 | 1,039 |
1237 | 32 | Black | 7 | 24 | 7 | 83,100 | 680 | 333 |
1238 | 42 | Caucasian | −31 | 35 | 45 | 99,600 | 367 | 367 |
1242 | 30 | Caucasian | −125 | 24 | 42 | 96,900 | 880 | 1,500 |
1245 | 32 | Caucasian | 4 | 59 | 67 | 39,562 | 777 | 587 |
1252 | 38 | Caucasian | −24 | 30 | 3 | 3,250,000 | 381 | 127 |
1261 | 23 | Caucasian | −306 | 16 | 16 | 25,000 | 990 | 855 |
1282 | 31 | Caucasian | 4 | 24 | 4 | 800,000 | 639 | 867 |
1294 | 26 | Hispanic | −43 | 48 | 44 | 1,749,236 | 718 | 1,144 |
1362 | 24 | Caucasian | 8 | 22 | 8 | >800,000 | 876 | 786 |
1372 | 36 | Caucasian | 0 | 19 | 19 | 39,746 | 939 | 755 |
1394 | 45 | Caucasian | −2 | 75 | 75 | 3,428 | 645 | 510 |
1396 | 39 | Caucasian | 27 | 32 | 32 | 750,000 | 686 | 1,346 |
1397b | 36 | Caucasian | −42 | 44 | 48 | 752 | 757 | 426 |
1408 | 33 | Caucasian | 3 | 14 | 3 | >500,000 | 397 | 629 |
1410 | 39 | Caucasian | −89 | 74 | 91 | 31,537 | 412 | 528 |
Mean | 32 | −40 | 32 | 37 | 497,442 | 656 | 750 |
EIA, enzyme immunoassay; dpi, days postinfection.
Subject 1397 was the only study participant who was not diagnosed with acute infection on the basis of acute symptoms. His date of infection was designated as the midpoint between the last negative and the first positive enzyme immunoassay.